Fig. 10From: A novel immunogenic cell death-related classification indicates the immune landscape and predicts clinical outcome and treatment response in acute myeloid leukemiaThe clinical cohort was used to validate the expression of risk score model genes. Differences in the expression of risk-scoring model genes among normal samples, myeloid leukemia chronic-phase samples, and myeloid leukemia acute-phase samplesBack to article page